NEW YORK and NEW ORLEANS, Dec. 30, 2025 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Please replace the release issued December 29, 2025 with the following corrected version due to multiple revisions. The updated release reads: DYNAVAX INVESTOR ALERT: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF DYNAVAX TECHNOLOGIES CORPORATION - DVAX Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale o.

Dynavax Technologies Corporation (NASDAQ: DVAX - Get Free Report) COO David Novack sold 30,000 shares of the company's stock in a transaction that occurred on Wednesday, December 24th. The shares were sold at an average price of $15.49, for a total value of $464,700.00. Following the completion of the transaction, the chief operating officer directly owned

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Dynavax Technologies Corporation (NasdaqGS: DVAX) to Sanofi (NYSE: SNY). Under the terms of the proposed transaction, shareholders of Cidara will receive $221.50 in cash for each share of Cidara that they own. KSF is seeking to determine whether this consideration and the process that led to it.

/PRNewswire/ -- The Ademi Firm is investigating DigitalBridge (Nasdaq: DVAX) for possible breaches of fiduciary duty and other violations of law in its

Exchange Traded Concepts LLC raised its position in shares of Dynavax Technologies Corporation (NASDAQ: DVAX) by 50.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 200,976 shares of the biopharmaceutical company's stock after acquiring an additional 67,375 shares during the quarter. Exchange

US stock futures slightly lower. Stocks to watch: NVIDIA, Dynavax, Sobr Safe, Davis Commodities, Biohaven.

Dynavax Technologies shares jumped more than 38% Wednesday after Sanofi announced a $15.50-per-share acquisition offer, valuing the company at roughly $2.2 billion.

Sanofi is launching an all-cash tender offer for Dynavax's shares. The French pharma giant's bid comes at a sizable premium to Dynavax's recent closing price.